You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
啓迪藥業(000590.SZ):已與寧波醫多多共設湖南啓迪藥業生物
格隆匯 12-10 19:30

格隆匯12月10日丨啓迪藥業(000590.SZ)公佈,公司日前已與寧波醫多多電子商務有限公司(“寧波醫多多”)共同出資設立“湖南啓迪藥業生物有限公司”(“合資公司”)。合資公司註冊資本爲500萬元人民幣,其中,公司以自有資金出資人民幣350萬元,持有合資公司70%股權,爲合資公司的控股股東;寧波醫多多出資人民幣150萬元,持有合資公司30%股權。

截至公告披露日,合資雙方簽署投資合作協議完成合資公司設立冊登記

雙方共同整合醫藥產業供應鏈資源在醫藥產業原材料耗材成品的交易爲主導以供應鏈集合採購和供應鏈創新服務爲雙輪驅動整合各種優質行業資共同孵化產業集羣增加企業利潤,創造社會價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account